NEUROPATHIX, INC. (KLFE) [Rocket]

In millions, except per share items	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
	10-K	10-K	10-K	10-K	10-K	10-K	S-1/A
Revenues	0.0	0.1	0.2	0.0	0.0	0.1	0.0
Revenue growth	-100.0%	-27.5%		-100.0%	-75.9%	2800.0%
Cost of goods sold	0.0	0.0	0.0	0.0	0.0	0.1	0.0
Gross profit	0.0	0.1	0.2	0.0	0.0	0.1	0.0
Gross margin		100.0%	100.0%		39.9%	64.8%	100.0%
Selling, general and administrative [+]	4.5	2.5	1.2	1.2	0.0	0.1	0.0
Sales and marketing					0.0	0.1
General and administrative				1.2	0.0	0.0	0.0
Research and development				0.0
Other operating expenses	0.1	2.2	-5.6
EBITDA [+]	-4.6	-4.6
EBITDA growth	0.4%	-200.4%	-485.4%	3584.9%	-775.3%	-158.4%
EBITDA margin		-3623.9%	2615.4%		-91.6%	3.3%	-162.3%
Depreciation	0.0	0.0
EBITA	-4.6	-4.6	4.5	-1.2	0.0	0.0	0.0
EBITA margin		-3628.3%	2615.4%		-91.6%	3.3%	-162.3%
Amortization of intangibles				0.0
EBIT [+]	-4.6	-4.6	4.5	-1.2	0.0	0.0	0.0
EBIT growth	0.6%	-200.5%	-480.8%	3629.6%	-775.3%	-158.4%
EBIT margin		-3628.3%	2615.4%		-91.6%	3.3%	-162.3%
Interest expense				0.1
Interest expense	0.9	0.1	0.0	0.1
Other income (expense), net	1.0	1.3	-2.8
Pre-tax income	-4.5	-3.5	1.7	-1.3	0.0	0.0	0.0
Income taxes	0.0	0.0	0.8	0.4	0.0	0.0	0.0
Tax rate	0.0%	0.0%	46.6%		0.0%	0.0%	0.0%
Net income	0.0	0.0	0.0	-1.6	0.0	0.0	0.0
Net margin		0.0%	0.0%		-91.6%	3.3%	-162.3%

Basic EPS [+]	$0.00	$0.00	$0.00	($0.03)	$0.00	$0.00	$0.00
Growth			-100.0%	908.2%	-775.3%	-158.4%
Diluted EPS [+]	$0.00	$0.00	$0.00	($0.03)	$0.00	$0.00	$0.00
Growth			-100.0%	908.2%	-775.3%	-158.4%

Shares outstanding (basic) [+]	74.6	71.2	64.4	48.5	9.5	9.5	9.5
Growth	4.8%	10.6%	32.8%	409.0%	0.0%	0.0%
Shares outstanding (diluted) [+]	74.6	71.2	68.8	48.5	9.5	9.5	9.5
Growth	4.8%	3.5%	41.9%	409.0%	0.0%	0.0%

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.